AstraZeneca breast cancer drug fails trial but Citi keeps buy rating
Analysts say the SERENA-4 setback for camizestrant does little damage and maintain their £178 target price on the shares
Company
AstraZeneca PLC
LON:AZN
AstraZeneca is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease. AstraZeneca has over 67,000 empolyees and operates in over 100 countries with growing presence in important emerging markets.
1085 stories · page 1 of 11